Advanced Oncotherapy – Has Odey Doubled Down In Face Of Embarrassment Of Insolvency?
AIM-listed Advanced Oncotherapy (AVO) has announced that Odey Asset Management is coughing up another £4.5 million as part of a £6 million fundraise to add to its investment in March of £2 million, again at 25p a pop – the par price. So is this an act of faith by Odey, or a case of if you owe the bank a million quid then it is the bank which has a problem?
- By Nigel Somerville, the Deputy Sheriff of AIM
- 2022-06-28 09:25:53